Article
Fusion-derived phospho-neoepitopes define a prioritized candidate neoantigen repertoire in MASLD-HCC
2026-08-27
Abstract excerpt
<h4>ABSTRACT</h4> <h4>Background</h4> The rising burden of metabolic dysfunction-associated steatotic liver disease (MASLD)-associated hepatocellular carcinoma (HCC) underscores the need for innovative therapeutic strategies. <h4>Methods</h4> We integrated RNA-seq fusion detection, immunopeptidomics, and proteogenomics to systematically prioritize tumor-specific neoantigen candidates arising from gene fusions i...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 06b1bb1e-6bd0-598f-a154-3f95e650eeeb
- DOI
- 10.64898/2026.08.26.747243
